Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
Phase 2
Withdrawn
- Conditions
- Cervical Intraepithelial Neoplasia
- Interventions
- Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- DFB Soria, LLC
- Registration Number
- NCT03143491
Study of SOR007 Ointment for Actinic Keratosis
Phase 2
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) OintmentOther: SOR007 Ointment Vehicle
- First Posted Date
- 2017-03-20
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- DFB Soria, LLC
- Target Recruit Count
- 33
- Registration Number
- NCT03083470
- Locations
- 🇺🇸
Moore Clinical Research, Tampa, Florida, United States
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SOR007 Ointment 2.0%Drug: SOR007 Ointment 1.0%Drug: SOR007 Ointment 0.3%Drug: SOR007 Ointment 0.15%Drug: SOR007 Ointment Placebo
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- DFB Soria, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT03004339
- Locations
- 🇺🇸
DermResearch, Inc., Austin, Texas, United States
🇺🇸J&S Studies, Inc., College Station, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath